SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-046395
Filing Date
2015-02-12
Accepted
2015-02-12 14:31:59
Documents
2
Group Members
EGOR KULKOVMARIA CHRISTINA STEPHANOUPANTELITSA SOFOKLEOUSVIKTOR KHARITONIN

Document Format Files

Seq Description Document Type Size
1 SC 13G d869930dsc13g.htm SC 13G 104046
2 EX-99.1 d869930dex991.htm EX-99.1 6055
  Complete submission text file 0001193125-15-046395.txt   111982
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 15605142
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 DIMOKRITOU, PANARETOS ELIANA COMPLEX OFC/FLAT 104, 4041 POTAMOS GERMASOGEIAS LIMASSOL G4 4041
Business Address 15 DIMOKRITOU, PANARETOS ELIANA COMPLEX OFC/FLAT 104, 4041 POTAMOS GERMASOGEIAS LIMASSOL G4 4041 357-25-028508
Augment Investments Ltd. (Filed by) CIK: 0001633168 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G4 | Fiscal Year End: 1231
Type: SC 13G